In the week of June 28, 2026, the RCM landscape showcased a significant influx of capital directed towards innovative technologies aimed at enhancing patient care and operational efficiency. With substantial investments in AI-driven solutions and automation, particularly in chronic disease management and voice technology, this week's deals highlight a clear trend: investors are increasingly focused on supporting advancements that promise to streamline healthcare delivery and improve compliance. The collective momentum suggests a robust appetite for funding solutions that leverage artificial intelligence to transform the healthcare ecosystem.
STAT News
A startup focused on developing treatments for eye diseases has secured $330 million in funding to prepare for late-stage testing. This significant investment highlights the growing interest and potential in the ophthalmology sector, indicating a shift towards more robust funding for innovative healthcare solutions. The influx of capital could accelerate advancements in the revenue cycle management (RCM) market as new therapies necessitate improved billing and reimbursement processes.
Source →Fierce Healthcare
Coval has raised $28 million in a Series A funding round to enhance the reliability and compliance of its AI voice agent technology. The company intends to use the capital to expand its sales and solutions engineering teams, as well as to improve its product capabilities. This funding could significantly impact the RCM market by potentially increasing the adoption of AI voice solutions in revenue cycle management processes.
Source →STAT News
Digital health startup Cadence has secured $100 million in funding, achieving a valuation of $1.23 billion, to enhance its automated chronic disease management program using regulated AI. This investment underscores the growing emphasis on technology-driven solutions in the revenue cycle management (RCM) sector, particularly for chronic disease care. The key implication for the RCM market is the potential for improved efficiency and outcomes in managing chronic conditions through advanced digital tools.
Source →Healthcare IT Funding & M&A (Google News)
Eolas Medical has raised £8.9 million in a Series A funding round led by Acton Capital. This investment aims to enhance Eolas Medical's capabilities in revenue cycle management (RCM) within the healthcare sector. A key implication for the RCM market is the potential for improved financial efficiency and innovation in healthcare billing processes as new technologies are developed.
Source →Fierce Healthcare
Assort Health raised $120 million in a Series C funding round to expand its voice AI agent platform tailored for healthcare, leveraging a proprietary dataset that includes 190 million patient interactions and 62,000 care protocols. This significant investment will enable Assort Health to enhance its AI capabilities, potentially transforming patient care and operational efficiencies in revenue cycle management (RCM). The key implication for the RCM market is the increased integration of AI technologies, which could streamline processes and improve patient outcomes.
Source →Every deal, every week
Subscribe to the RevCycleAI newsletter. Free weekly RCM intelligence — deals, payer moves, and vendor deep dives.
Subscribe Free →